SA
HRMY icon

Sanctuary Advisors’s Harmony Biosciences HRMY Stock Holding History

Sanctuary Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36,778
Closed -$1.03M – 2894
2026
Q1 		$1.03M Buy
+36,778
New +$1.21M 0.01% 1318
2025
Q2 		– Sell
-45,905
Closed -$1.52M – 2394
2025
Q1 		$1.52M Buy
+45,905
New +$1.65M 0.01% 910

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanctuary Advisors's HRMY Position: Q2 2026 in Review

Sanctuary Advisors sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 36,778 shares — an estimated $1.03M sold.

Sanctuary Advisors first reported a position in HRMY in Q1 2025 and held it in 2 quarters. The position peaked at $1.52M in Q1 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Sanctuary Advisors reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Sanctuary Advisors sold 36,778 Harmony Biosciences shares in Q2 2026, an estimated $1.03M.
  • Sanctuary Advisors first reported a position in Harmony Biosciences in Q1 2025 and held it in 2 quarters.
  • Sanctuary Advisors's Harmony Biosciences position peaked at $1.52M in Q1 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.